HoxB5 Activators
HoxB5 Activators encompass a series of chemical compounds that facilitate the enhancement of HoxB5 function by modulating various cellular signaling pathways and influencing gene expression. Lithium Chloride, by inhibiting GSK-3 within the Wnt signaling pathway, induces the stabilization of β-catenin, which is crucial for enhancing HoxB5's role in development and differentiation. Similarly, Forskolin and Dibutyryl-cAMP raise intracellular cAMP levels, leading to PKA activation. This cascade of events potentially augments HoxB5 activity by fostering the phosphorylation of transcription factors that regulate developmental genes. Retinoic Acid, by interacting with RAR, has the potential to increase HoxB5 activity through gene regulation during developmental stages. In parallel, Trichostatin A and Sodium Butyrate, both HDAC inhibitors, facilitate a more open chromatin structure, thereby possibly enhancing gene expression and subsequently HoxB5 activity.
In addition to these, 5-Azacytidine, through its DNA methyltransferase inhibitory action, can lead to the activation of genes by reducing methylation, which may include the enhancement of HoxB5 function. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which can modify transcription factor activities, potentially amplifying HoxB5's influence on cellular differentiation. Kinetin, although with a less clear mechanism, is suggested to modulate gene expression patterns that could enhance HoxB5 function. Furthermore, β-estradiol, by activating estrogen receptors, can have a regulatory effect on gene expression, possibly promoting HoxB5 activity in developmental contexts. Vitamin D3, through the vitamin D receptor, regulates genes involved in development, potentially enhancing HoxB5's role. Rapamycin, by inhibiting mTOR, may induce changes in gene expression patterns, thereby facilitating HoxB5 activity in development and differentiation pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride influences the Wnt signaling pathway by inhibiting GSK-3, leading to the stabilization and accumulation of β-catenin. This accumulation can enhance HoxB5 activity as HoxB5 can be regulated by β-catenin, which is part of the canonical Wnt signaling pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which in turn activates PKA. Activated PKA can phosphorylate transcription factors that may influence HoxB5-associated gene expression, thereby enhancing HoxB5's activity in cellular differentiation processes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid acts on the retinoic acid receptor (RAR), which regulates gene expression, including genes involved in development. HoxB5 is known to be regulated by retinoic acid during certain developmental stages, indicating that retinoic acid can enhance HoxB5 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDACs). By inhibiting HDACs, it leads to a more relaxed chromatin structure, allowing increased access for transcription factors to DNA, which could result in enhanced expression and activity of HoxB5. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA and RNA and inhibits DNA methyltransferase, leading to decreased DNA methylation. This reduction in methylation can activate certain genes by allowing transcription factors to access DNA, potentially increasing HoxB5 activity through epigenetic modification. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in various signal transduction pathways. PKC activation can lead to changes in transcription factor activities, potentially enhancing HoxB5's role in cell differentiation and development. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a short-chain fatty acid, acts as an HDAC inhibitor, leading to hyperacetylation of histones and a more open chromatin structure. This increased accessibility to transcription machinery can enhance HoxB5 activity by promoting gene transcription. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA, mimicking the effects of Forskolin. This activation can lead to enhanced transcription factor activity, which may include factors that regulate HoxB5 expression and function. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $38.00 $48.00 | ||
Kinetin is known to affect cellular proliferation and differentiation. Though its mechanism is not fully understood, it can influence gene expression patterns in development, potentially enhancing HoxB5 activity through modulation of transcription factors involved in development. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-estradiol binds to estrogen receptors, which can regulate gene expression. Through this receptor-mediated action, β-estradiol may enhance the expression and activity of HoxB5, which plays a role in development and differentiation. | ||||||